Morning Headlines 5/20/19
JP Morgan Chase will acquire medical payments platform vendor InstaMed for more than $500 million.
Patient Hurt by Do-It-Yourself Artificial Pancreas Prompts FDA Warning
FDA warns users of do-it-yourself artificial pancreas systems that the individual components, including software, don’t necessarily work together to accurately control blood glucose levels.
UPMC Starts Telemedicine Company to Fight Infectious Disease
UPMC (PA) commercializes the infectious disease telemedicine services it has provided to patients over the last five years with the formation of Infectious Disease Connect.
Health at Scale lands $16M Series A to bring machine learning to healthcare
Optum invests $16 million in San Jose, CA-based precision care delivery startup Health at Scale.
"A valid concern..." Oh please. Everyone picks the software they like and the origin of that software is an afterthought.…